Navigation Links
DS Chemphy Focusing on CRO/CMO Business
Date:2/9/2010

WILMINGTON, Del., Feb. 9 /PRNewswire/ -- The rapid increase of cost in China has brought some shadow to the CRO and CMO businesses there. However, DS Chemphy, Inc., a USA-based contract research and manufacturing organization that focuses on fine and pharmaceutical chemicals, continues investing in its businesses. "Our competitive advantages are not only low costs," said Dr. Aaron Shen, CEO of the company.

Dr. Shen continues: "What makes Chemphy so attractive to our customers? The answers are: high-standard EHS management, high quality products and services, proprietary technologies, high efficiency, excellent IP protection, active communication, and integrated capability from R&D to manufacture."

Since DS Chemphy acquired New Chemphy in 2007, DS Chemphy has invested over $45 million in CRO/CMO capability as well as corporate culture and management reform. New Chemphy was founded by the Chinese Academy of Sciences. DS Chemphy integrated Chinese and Western advantages, i.e. lower costs of China and high-standard quality management of the West. The successful story was reported by C&E News (Issue Sept 1, 2008, page 35).

Most senior executives of the company have overseas training or work experience. The company now employs over 1000 chemical professionals. Last year, the company built a world-class R&D center. 150 chemists, including 25 PhDs, work in the center. The labs are equipped with state-of-the-art instruments including NMR, LC-MS, GC-MS, DSC, RC1, and GPC. The company has two manufacturing sites capable of production at pilot, multi-functional, and commercial scale. The reactors cover all sizes up to 20M(3). The reactors are either made of stainless steel, or glass-lined, nickel-lined, titanium-lined, Hastelloy-lined or polytetrafluoroethylene-lined.

DS Chemphy offers quality products based on Chemphy proprietary technology platforms including cyclopropanation, fluorination, and catalytic continues process, etc.

Recently DS Chemphy launched three new products:

Cyclopentyl methyl ether -- THF alternative

ChemphySteel® -- Polymers as strong as steel

ChemphyFresh® -- Keep your fruits and vegetables fresh

Visit us at booth 117 at InformEx USA, San Francisco, CA February 16-19, 2010, or www.dschemphy.com. You may also contact Aaron Shen, President of DS Chemphy at tel: 302-351-8401, fax: 302-351-6101 or email: ashen@dschemphy.com.

SOURCE DS Chemphy, Inc.

RELATED LINKS
http://www.dschemphy.com

'/>"/>

SOURCE DS Chemphy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Immtech Focusing on Other Infectious Disease Programs Following Discontinuation of Development of Pafuramidine
2. EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimers, Schizophrenia and Huntingtons Diseases
3. Hopkins Report: Focusing on Family Planning Lessens HIV Impact
4. Babson Executive Education Offers Bio-Pharma: Mastering the Business of Science
5. Centerphase Solutions, Inc. Launches New Clinical Trials Business Model Company
6. Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions
7. Los Angeles Business Owner Pleads Guilty to Submitting Nearly $1 Million in False and Fraudulent Claims to Medicare
8. Highlights of Economic and Business Growth in the Tampa Bay Region
9. Solos Endoscopy, Inc. Set to Increase Business Through Sales and Product Development in 2010
10. PDI Announces New Pharmaceutical Services Business Win With a Top 5 Pharmaceutical Company
11. Pfizer Whistleblower Named Years Most Influential Person In Business Ethics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Wegener Polyangiitis - Pipeline Review, H2 ... Polyangiitis - Pipeline Review, H2 2015, provides an ... This report provides comprehensive information on the therapeutic ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ...
(Date:2/4/2016)... Frontier Pharma: Chronic Obstructive Pulmonary Disease ... Chronic Obstructive Pulmonary Disease (COPD) is ... the airways and lungs. Persistent breathing difficulties and ... one of the leading causes of morbidity and ... COPD is linked to cumulative exposure to risk ...
(Date:2/4/2016)... 2016 In response to the opioid abuse epidemic, ... for Medical Products and Tobacco, along with other FDA leaders, ... approach to opioid medications. The plan will focus on policies ... pain access to effective relief. --> ... Re-examine the risk-benefit paradigm for opioids and ensure that the ...
Breaking Medicine Technology:
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Steven Tonkinson, ... he has completed every year since it started in 2003. This year, he ran ... attention of fellow runners and NBA team the Miami Heat. , This Sunday, while ...
(Date:2/5/2016)... ... February 05, 2016 , ... Today, the Whole-Food Warrior TV show, ... much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, will stream on ... week, on his weekly Whole-Food Warrior TV show, Frank Davis highlights Whole-Food Warriors - ...
(Date:2/5/2016)... ... 05, 2016 , ... The Muscular Dystrophy Association and Sailormen ... the 14th annual “Appetite for a Cure” campaign on Feb. 1 to raise ... related diseases that severely limit strength and mobility. , Now through March ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... George H. Van Allen have signed a joint enrollment and degree completion agreement. ... pathway toward associate and baccalaureate degrees at FHU|Dickson. , The agreement allows ...
(Date:2/5/2016)... ... 2016 , ... US Sports Camps , official operators of Nike Yoga ... kids yoga training. ChildLight Yoga Studio is centrally situated in the picturesque New England ... Yoga Studio founder Lisa Flynn expresses her excitement, “We are thrilled to be partnering ...
Breaking Medicine News(10 mins):